default author photo

Robert James Hamilton

University of Toronto - Princess Margaret Cancer Centre

SCHOLARLY PAPERS

2

DOWNLOADS

130

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

The Metformin Active Surveillance Trial for Low-Risk Prostate Cancer

Number of pages: 24 Posted: 16 Apr 2025
University of Toronto - University Health Network, Princess Margaret Hospital, University of Western Ontario, University of Manitoba, affiliation not provided to SSRN, Nanostics Inc, McGill University - McGill University Health Centre, affiliation not provided to SSRN, University of Montréal - Cancer Prognostics and Health Outcomes Unit, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Toronto, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Toronto - Princess Margaret Cancer Centre, affiliation not provided to SSRN, University of Toronto - University Health Network, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Toronto - Princess Margaret Cancer Centre, University of Toronto - University Health Network, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and The Kinghorn Cancer Centre
Downloads 80 (816,709)

Abstract:

Loading...

Metformin, Prostate Cancer, Active Surveillance

2.

Primary Retroperitoneal Germ-Cell Tumours (pR-GCT): Evaluation of Treatment Outcomes of An International Collaboration (PRIMERE Study-IGG05)

Number of pages: 27 Posted: 28 Oct 2025
Fondazione IRCCS Istituto Nazionale dei Tumori - Department of Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre, University of Cologne - University Hospital of Cologne, University of Cologne, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Dana-Farber Cancer Institute, Dana-Farber Cancer Institute, Comenius University, Veneto Institute of Oncology IOV - IRCCS, Veneto Institute of Oncology IOV - IRCCS, University of Groningen, University Medical Centre Groningen, Fondazione IRCCS Policlinico San Matteo, University of Pavia, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST), University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Pavia, University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori and Fondazione IRCCS Istituto Nazionale dei Tumori
Downloads 50 (1,063,489)

Abstract:

Loading...

Primary Retroperitoneal Cancer, Germ Cell Tumor, Prognosis, Extragonadal Germ Cell Tumors